FLGT vs WVE
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
FLGT · Fulgent Genetics$23.74 ▲ 27.22%
WVE · Wave Life Sciences$3.37 ▲ 4.50%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- FLGT -12.6%
- WVE -52.2%
Head to head
| Metric | FLGT | WVE |
|---|---|---|
| Price | $23.74 | $3.37 |
| Change today | ▲ 27.22% | ▲ 4.50% |
| Market cap | $663.27M | $663.68M |
| Return, 3 months | +24.6% | -44.6% |
| Return, year to date | -9.6% | -80.2% |
| Return, 1 year | -9.9% | -57.2% |
| P/E (TTM) | – | – |
| P/B | 0.7 | 1.7 |
| P/E percentile vs own 5y | 45th | 64th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +4.4% | +72.9% |
| Net profit growth (YoY) | -54.3% | -15.0% |
| Gross margin | 35.6% | – |
| Operating margin | -37.1% | -320.9% |
| Net margin | -26.0% | -296.9% |
| Return on equity | -8.0% | -80.0% |
| Analyst target vs. price | -20.0% | +410.3% |
| Analyst buy share | 0% | 94% |
| RSI (14) | 64 | 44 |
| 30-day volatility | 88.3% | 64.8% |
| Max drawdown, 1 year | -55.3% | -85.5% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- WVE is the largest of the group by market value.
- FLGT has returned the most over the past year.
- WVE is growing revenue fastest.
- FLGT keeps the most profit per dollar of sales.
- WVE has been the calmest stock over the last 30 days.